The document discusses a decision support system called CEPHOS-LINK DSS that was designed to aid policy makers and stakeholders in understanding factors that may impact psychiatric rehospitalization. The system generates scenarios using data from 6 European countries to model how resources could be allocated and services planned. It is intended as a proof of concept that could potentially be expanded to include additional countries and data sources. The overall goal is to facilitate discussion between sectors and provide an accessible way to explore rehospitalization issues in different contexts.
Alisdair Ritchie gave a presentation talking about the work PETRAS is doing to protect and secure IoT devices.
This slideshare was originally presented at the East Midlands Cyber Security Forum's Summer event on 6th June 2017 at University of Nottingham.
https://emcsf.org.uk/
This event provided insight for organisations considering adopting Internet of Things (IoT) technology from a business perspective, and included the advantages of connecting things and the security implications of doing so.
https://emcsf.org.uk/
Digitalisation and the future of research environmentsJisc
A presentation by Professor Balbir Barn from our 'Shaping future research environments: digital challenges and opportunities' event on 15 December 2020.
Alisdair Ritchie gave a presentation talking about the work PETRAS is doing to protect and secure IoT devices.
This slideshare was originally presented at the East Midlands Cyber Security Forum's Summer event on 6th June 2017 at University of Nottingham.
https://emcsf.org.uk/
This event provided insight for organisations considering adopting Internet of Things (IoT) technology from a business perspective, and included the advantages of connecting things and the security implications of doing so.
https://emcsf.org.uk/
Digitalisation and the future of research environmentsJisc
A presentation by Professor Balbir Barn from our 'Shaping future research environments: digital challenges and opportunities' event on 15 December 2020.
EOSC Governance Session - EOSC Stakeholders Forum 2018EOSCpilot .eu
The key objective for the Governance Work is to design and trial a stakeholder driven governance framework with the involvement of research communities, research institutions, research infrastructures including e-infrastructures, and research funding bodies, to shape and oversee future development of the European Open Science Cloud.
Presentation: ODINE - Open Data Incubator Europe, by Elena Simperl, University of Southampton & The ODI (UK), at the European Data Economy Workshop taking place back to back to SEMANTiCS2015 on 15 September 2015 in Vienna
Resilience Shift Policy Symposium - the role of public policy - Dr Svenja KeeleThe Resilience Shift
The Resilience Shift Policy Symposium took place on Wed 15 May 2019 in Melbourne Australia. This presentation was by Dr Svenja Keele and Professor Lars Coenen, from the University of Melbourne, who talked about the role of policy and the ‘policy spectrum’ as captured in the published report. The Symposium explored ways to incentivise resilience - by understanding the key drivers, and exploring the use of different policy approaches to enhance critical infrastructure resilience.
Preventive healthcare: exploring big data’s rising role in active and healthy ageing
As healthcare costs continue to soar, the cost saving benefits of big data will become more apparent, especially as there is an increased focus on preventive care, well-being and reducing re-admission rates in the hospital. With so many benefits, it’s easy to understand why the healthcare industry has been such an early adopter of big data technology.
However, it would be interesting to see the impact big data has on the active and healthy ageing market as we are moving forward.
Indeed, can we imagine using personal health data for encouraging persons to be proactive about their health and implement suggested lifestyle changes?
To which extent can this information be used by insurance companies for example?
Which challenges encountered when collecting this data?
Let’s discuss with our panelists the impact big data has on preventive care and which are its limits?
Moderator: Bowden Richie, CEO, SoMoMod/ Assess Patients, IE
O'Donoghue John, Senior Lecturer in eHealth & Deputy Director Global eHealth, IMPERIAL COLLEGE LONDON, UK
Dekezel Stefaan, Programme Director Innovation & Smart Synergies, Ageas, BE
Brichet Francis, Health Manager, Coreye, FR
The view of interoperability and standards:
(1) Standards as infrastructure for interoperability
(2) Placing the citizen at the center
(3) Using digital health technologies to reduce costs and flatten risk
(4) However we face a tsounami of data; the question do you navigate the data? Can standards help? And what kind standards can help? Establish trust, use the right data at the right time, for the benefit of the patient; and the system as a whole.
(a) Example of appointments: replace most routine f2f appointments with remote visits; and shift the focus to f2f visits that aim to diagnose a problem. Productivity low in health care.
(b) Standards place the individual at the center of the care serving as the data aggregator in a fragmented health system
(c) Think of the patient summary as a window to a persons’ health
Complying with EPSRC policy: An LSHTM case studyGarethKnight
Overview of LSHTM's approach to complying with EPSRC data management requirements, focussed on security requirements. Presented at Glasgow University on May 8th 2014
"Improving Decision Making in Health & Social Care Through Quality Information & Technology": Dr. Mark Davies (Director of Clinical and Public Assurance) of the Health and Social Care Information Centre (HSCIC) discusses this at the Healthcare Efficiency Through Technology Expo 2013.
How Effective Research Can Support Policy and Practice Development E17Sophie40
Session on the work of CELCIS’s Permanence and Care Team (PaCT) whose role is to support local authorities in improving permanence process and practice for looked after children. Contributed by: CELCIS
HESA data, describing research activity and #REF2021Jisc RDM
Research Data Network
Dan Cook, Head of Data Policy & Development at HESA;
An update on the work Hesa is doing in relation to research data, especially in the context of the forthcoming REF.
Mobilising Evidence for Good Governance - OECD Presentation by Stéphane Jacob...OECD Governance
OECD Presentation by Stéphane Jacobzone on Mobilising Evidence for Good Governance. For further information see: http://www.oecd.org/gov/mobilising-evidence-for-good-governance-3f6f736b-en.htm
EOSC Governance Session - EOSC Stakeholders Forum 2018EOSCpilot .eu
The key objective for the Governance Work is to design and trial a stakeholder driven governance framework with the involvement of research communities, research institutions, research infrastructures including e-infrastructures, and research funding bodies, to shape and oversee future development of the European Open Science Cloud.
Presentation: ODINE - Open Data Incubator Europe, by Elena Simperl, University of Southampton & The ODI (UK), at the European Data Economy Workshop taking place back to back to SEMANTiCS2015 on 15 September 2015 in Vienna
Resilience Shift Policy Symposium - the role of public policy - Dr Svenja KeeleThe Resilience Shift
The Resilience Shift Policy Symposium took place on Wed 15 May 2019 in Melbourne Australia. This presentation was by Dr Svenja Keele and Professor Lars Coenen, from the University of Melbourne, who talked about the role of policy and the ‘policy spectrum’ as captured in the published report. The Symposium explored ways to incentivise resilience - by understanding the key drivers, and exploring the use of different policy approaches to enhance critical infrastructure resilience.
Preventive healthcare: exploring big data’s rising role in active and healthy ageing
As healthcare costs continue to soar, the cost saving benefits of big data will become more apparent, especially as there is an increased focus on preventive care, well-being and reducing re-admission rates in the hospital. With so many benefits, it’s easy to understand why the healthcare industry has been such an early adopter of big data technology.
However, it would be interesting to see the impact big data has on the active and healthy ageing market as we are moving forward.
Indeed, can we imagine using personal health data for encouraging persons to be proactive about their health and implement suggested lifestyle changes?
To which extent can this information be used by insurance companies for example?
Which challenges encountered when collecting this data?
Let’s discuss with our panelists the impact big data has on preventive care and which are its limits?
Moderator: Bowden Richie, CEO, SoMoMod/ Assess Patients, IE
O'Donoghue John, Senior Lecturer in eHealth & Deputy Director Global eHealth, IMPERIAL COLLEGE LONDON, UK
Dekezel Stefaan, Programme Director Innovation & Smart Synergies, Ageas, BE
Brichet Francis, Health Manager, Coreye, FR
The view of interoperability and standards:
(1) Standards as infrastructure for interoperability
(2) Placing the citizen at the center
(3) Using digital health technologies to reduce costs and flatten risk
(4) However we face a tsounami of data; the question do you navigate the data? Can standards help? And what kind standards can help? Establish trust, use the right data at the right time, for the benefit of the patient; and the system as a whole.
(a) Example of appointments: replace most routine f2f appointments with remote visits; and shift the focus to f2f visits that aim to diagnose a problem. Productivity low in health care.
(b) Standards place the individual at the center of the care serving as the data aggregator in a fragmented health system
(c) Think of the patient summary as a window to a persons’ health
Complying with EPSRC policy: An LSHTM case studyGarethKnight
Overview of LSHTM's approach to complying with EPSRC data management requirements, focussed on security requirements. Presented at Glasgow University on May 8th 2014
"Improving Decision Making in Health & Social Care Through Quality Information & Technology": Dr. Mark Davies (Director of Clinical and Public Assurance) of the Health and Social Care Information Centre (HSCIC) discusses this at the Healthcare Efficiency Through Technology Expo 2013.
How Effective Research Can Support Policy and Practice Development E17Sophie40
Session on the work of CELCIS’s Permanence and Care Team (PaCT) whose role is to support local authorities in improving permanence process and practice for looked after children. Contributed by: CELCIS
HESA data, describing research activity and #REF2021Jisc RDM
Research Data Network
Dan Cook, Head of Data Policy & Development at HESA;
An update on the work Hesa is doing in relation to research data, especially in the context of the forthcoming REF.
Mobilising Evidence for Good Governance - OECD Presentation by Stéphane Jacob...OECD Governance
OECD Presentation by Stéphane Jacobzone on Mobilising Evidence for Good Governance. For further information see: http://www.oecd.org/gov/mobilising-evidence-for-good-governance-3f6f736b-en.htm
The EOSC-hub: Integrating and managing services for the European Open Science...EOSCpilot .eu
This presentation was held at the 1st EOSC Stakeholder Forum 28-29/11/2017 in Brussels by Tiziana Ferrari, EGI.eu.
For more information on the 1st EOSC Stakeholder Forum visit: https://eoscpilot.eu/eosc-stakeholder-forum-shaping-future-eosc
Follow EOSCpilot on Twitter: https://twitter.com/eoscpilot
and LinkedIn: https://uk.linkedin.com/in/eoscpiloteu
Peter Kraker, Michela Vignoli & Rainer Bachleitner give an overview of an innovative dissemination framework & present the OpenUP Innovative Dissemination Toolbox.
Workshop title: Innovative dissemination practices & Altmetrics
Workshop abstact:
The goal of the workshop is to further the understanding of innovative dissemination practices in open science and their relationship with altmetrics. In the first part of the workshop, OpenUP project researchers will give an overview of an innovative dissemination framework. The framework describes good practices and gives recommendations on how to create a successful research dissemination strategy beyond traditional academic dissemination. A special focus will lie on how to reach target audiences beyond the research community (e.g. business or the general public). Participants will be able to test the framework and a toolbox based on their dissemination needs and to give feedback in a discussion that involves the perspective of all stakeholders of dissemination and assessment (researchers and research organizations, funders, policy makers, journalists, practitioners & businesses etc.). In the second part, we will present a taxonomy linking channels of dissemination and altmetrics indicators. In between, we will present best practice examples of innovative dissemination.
DAY 2 - PARALLEL SESSION 3
http://opensciencefair.eu/workshops/parallel-day-2-1/innovative-dissemination-practices-and-altmetrics
License: CC-BY, unless otherwise noted
Linking Knowledge to Policy and Practice - Collaborative LearningEduSkills OECD
This presentation was given by Rien Rouw of the Ministry of Education of Holland at the CERI Conference on Innovation, Governance and Reform in Education on 3 November 2014 during session 3.a: Knowledge-intensive Governance, Innovation and Change.
Trust and Accountability to Support Effective Policymaking. Highlights of the Commission on Evidence-based Policymaking's recommendations that pertain to transparency, and recommendations for a panel of the National Academies to consider. September 9, 2019
First eStandards conference Panel of the European SDO Platformchronaki
Introduction to panel where Standards Developing Organization and National Competence Centers discuss the scope of the European SDO platform reflecting on earlier presentations.
Data ecosystems: turning data into public valueSlim Turki, Dr.
Africa Information Highway Live Exchange #Session 7
8 October 2021
The AIH Live Exchange between the Africa Information Highway Team, partners and countries is a free monthly webinar hosted by the African Development Bank to discuss topics related to government data and statistics. This webinar series is the main platform for countries to share their experiences and best practices around open data including using their Open Data Platform of the AIH.
This session is co-organized with the Luxembourg Institute of Science and Technology (LIST) which is a mission-driven Research and Technology Organization (RTO) that develops advanced technologies and delivers innovative products and services to industry and society. These innovations can also be used to solve several societal challenges, particularly in the areas of the environment, security, education and culture, sustainable development, as well as the efficient use of resources.
Official statistical data are recognized as high-value datasets for the society and economy, to enrich research, inform decision making or develop new products and services. The use of these authoritative data sources contributes to building a society with more empowered people, better policies, more effective and accountable decision-making, greater participation and stronger democratic mechanisms.
Official statistics are produced to be used and re-used to make an impact on society through a higher degree of openness and transparency while ensuring confidentiality and, at the same time, providing equal access to information to citizens.
The value of data lies in its use and re-use. In this interactive webinar, you will learn new techniques to improve the use and re-use of your statistical data, going beyond the provision logic and adopting the ecosystem mindset. You will:
● Sharpen your capacity at identifying and engaging users and re-users and stakeholders (data ecosystem mapping)?
● Effectively tackle technical and organizational barriers to stimulate data use and re-use?
● Smartly orchestrate a self-sustainable data ecosystem to increase the impact of statistical data.
This session is an opportunity for Regional members countries to '' Sharpen their skills in making data used and re-used by developing an ecosystem mindset to effectively build sustainable community of users around their Open Data Platform thus promoting transparency and better decision-making”
Within the framework of its Research Communications Capacity Building Program, GDNet produced, in collaboration with CommsConsult, a series of handouts with the aim to help southern researchers communicate their work more effectively. This series help understand policy processes and influencing policy with research; provide some tips for writing a policy brief, explains how to communicate effectively with your target audience through different communication tools, and presenting some useful online tools for data visualization.
Putting Well-being Metrics into Policy Action, 3-4 October 2019, Paris, France. More information at: http://www.oecd.org/statistics/putting-well-being-metrics-into-policy-action.htm
What is e-research?
Enhancing research practice
e-Research Methods, Strategies, and Issues
Tips For Finding Useful Information
Some Search Tools for doing e-research
Research Design
Quantitative Research
Qualitative Research
Ethics & The e-Researcher
How The Net Complicates Ethics?
Privacy, Confidentiality, Autonomy, And The Respect For Persons
Tips For Ethical e-Research
Collaboration Tools
Why Consensus?
Net-based dissemination of E-research results
Dissemination through peer-reviewed articles
Advantages of a peer-reviewed article
Dissemination through email lists or Usenet groups
Dissemination through a virtual conference
Similar to Exploring re-hospitalisation using a Decision Support System. (20)
Kirsimarja Raitasalo, THL: Miksi päihdehaittoja on tärkeää ehkäistä kouluissa ja oppilaitoksissa - Nuorten päihteidenkäytön yleiskuva. Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022
Marke Hietanen-Peltola & Johanna Jahnukainen, THL: Miten opiskeluhuoltopalvelut tukevat hyvinvointia ja ehkäisevät päihdehaittoja. Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022.
Riina Länsikallio, OPH: Päihdekasvatus ja ehkäisevä päihdetyö kouluissa ja oppilaitoksissa. Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022
Jaana Markkula, THL, Ehkäisevä päihdetyö lasten ja nuorten hyvinvoinnin tukijana kouluissa ja oppilaitoksissa -verkkoaineisto sujuvamman työn tueksi -webinaari, 10.10.2022
What is the current Synthetic opioid situation in Europe? How can countries be better prepared and equipped for a continued rise in synthetic opioid prevalence, use, and incidents?
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
How to Give Better Lectures: Some Tips for Doctors
Exploring re-hospitalisation using a Decision Support System.
1. 22.8.2017 1
Exploring re-hospitalisation using a
Decision Support System
The CEPHOS-LINK DSS
Esityksen nimi / Tekijä
This project has received funding from the European Union’s Seventh Framework
Programme for research, technological development and demonstration under
grant agreement no 603264
2. Mental health policy making
POLICY
MAKING
Empirical
evidence
Politics/
philosophy
Economic
values
Social
values
Ethical
values
Personal
values
22.8.2017 Esityksen nimi / Tekijä 2
3. Lifting up empirical evidence
22.8.2017 Esityksen nimi / Tekijä 3
• Making evidence more accessible
• Facilitating discussion
• Connect different sectors
• Easy to use in different contexts
4. Decision Support Systems (DSS)
• Decision Support Systems (DSS) are computer based tools which
aid stakeholders and decision-makers to understand complex
scenarios and find the right solutions.
• The CEPHOS-LINK DSS is designed to aid policy makers and other
stakeholders understand different factors which may impact
psychiatric rehospitalisation and could aid with
resource allocation and service planning
• Generate discussion, model scenarios,
developing services
22.8.2017 Esityksen nimi / Tekijä 4
5. CEPHOS-LINK DSS
• Not a summary of our findings but a proof of concept tool using data
from the six countries involved in the study; Austria, Finland, Italy,
Norway, Romania and Slovenia.
• An additional way of exploring re-hospitalisation.
• Based on data from, Eurostat, WHO Mental Health Atlas 2011, and
The European House – Ambrosetti.
• Potential to be developed further by including data from other
countries, resulting in more variation, combinations and scenarios.
• http://www.dwh.at/cephos/
22.8.2017 Esityksen nimi / Tekijä 5